NDC 42858-601 – Buprenorphine and Naloxone

Buprenorphine Hydrochloride 2 mg/1; Naloxone Hydrochloride Dihydrate .5 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC42858-601

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
Rhodes Pharmaceuticals LLC
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA205601
Marketed since
April 13, 2020
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (1)

Package NDCDescriptionSince
42858-601-0330 TABLET in 1 BOTTLE, PLASTIC (42858-601-03)Apr 13, 2020

Other Buprenorphine and Naloxone products